Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… patients and their caregivers to help inform the drug development process. The Alzheimer’s Disease Patient and … With the scientifically-rigorous data from the study, drug developers will have a better understanding of outcomes …
2023 Italian Society of Hygiene, Preventive Medicine, and Public Health (SITI) Conference Share on: Thursday, October 12 - Saturday, October 14, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the 2023 …
… and access, in a variety of disease areas, including cancer, mental health, pain, cardiovascular disease, … at Chapel Hill. He possesses substantial experience in studying treatment patterns, health care utilization and … registries. Dr. Goyal also has experience in assessing adverse events, disease progression, medication adherence, …
… Our experience includes: Cardiovascular devices Cellular therapies that require device delivery systems Contrast media … diagnostics and personalized medicine products Novel drug delivery systems Orthopedic devices Pain management … Recent projects have included: Decision-analytic models Drug utilization studies Health preference assessment studies …
… pain management. Our experience includes: Acute pain Bone cancer Chronic pain Hemophilia Lower back pain Migraine …
… randomized clinical trials and robust information on rare adverse events was lacking. As the availability of real-world …
… States. It allows Medicare to negotiate prescription drug prices with manufacturers and put an inflation cap on … in January 2025 for new oncology medicines, advanced therapies (also known as cell and gene therapies), and medical technologies. As the HTAR moves along …
… illnesses. Benefit-risk preference studies Consulting on drug development and clinical trial design Database analyses … models (cost effectiveness, budget impact) Drug utilization studies Economic burden of illness studies …
Determining Effectiveness of Risk-Minimization Measures Impact of Risk Minimization Measures on the Use of Cilostazol in Europe J Castellsague, B Calingaert , B Poblador-Plou, M Giner-Soriano, M Linder, O Scholle, A Arana Navarro, C Bui , C Laguna, A …
… Transcript: Targeted treatments have emerged as frontline therapies for patients diagnosed with chronic lymphocytic …